Remote Technology overcomes COVID-Imposed Obstacles for Clinical Trials

Jul 16, 2020 by CenTrial



COVID-19 has created unique challenges for clinical trial studies such as travel restrictions and patient reluctance to visits sites.

CTI Clinical Trial and Consulting (CTI) and Medidata are now working together to facilitate remote monitoring of patients in order to mitigate these problems and allow trial sites and sponsors to continue their vital research.

"It's more important than ever that we think and plan our way around the obstacles COVID-19 has put in the path of medical progress," says Glen de Vries, co-founder, and co-CEO of Medidata.

Medidata Remote Source Review technology is already deployed in more than 15,000 clinical sites. Timothy Schroeder, Chief Executive Officer, and Founder, CTI explains, "Their scalable solutions will also take us beyond COVID-19. The future lies in minimizing disruptions to research, accelerating the move toward more virtual trial management, ensuring data collection and integrity, and managing source documents remotely, as needed."

---